Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease

British Journal of Dermatology

Volumn 148, Issue 3, 2003, Pages 539-543

  Salim, A ^a,c   Leman, J A ^a,c,d   McColl, J H ^b   Chapman, R ^c   Morton, C A ^a,d  

^a Ward 17 Falkirk Community Hospital   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

5 aminolaevulinic acid; 5 fluorouracil; Bowen's disease; Photodynamic therapy; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; FLUOROURACIL; POPHIN;

AGED; ARTICLE; BOWEN DISEASE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DISEASE SEVERITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG TOLERABILITY; ECZEMA; EROSION; FEMALE; HUMAN; HUMAN EXPERIMENT; ILLUMINATION; MALE; PAIN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; RED LIGHT; RISK; SKIN ULCER; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; ANTIMETABOLITES, ANTINEOPLASTIC; BOWEN'S DISEASE; FEMALE; FLUOROURACIL; HUMANS; MALE; PHOTOCHEMOTHERAPY; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0037362509     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05033.x     Document Type: Article

References (16)

1. Ball SB, Dawber RPR. Treatment of cutaneous Bowen's disease with particular emphasis on the problem of lower leg lesions. Australas J Dermatol 1998; 39: 63-70.
2. Roberts DJH, Cairnduff F. Photodynamic therapy of primary skin cancer: a review. Br J Plast Surg 1995; 48: 360-70.
3. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000; 42: 389-413.
4. Ormrod D, Jarvis B. Topical aminolevulinic acid HCl photodynamic therapy. Am J Clin Dermatol 2000; 1: 133-9.
5. Cox NH, Eady DJ, Morton CA. Guidelines for the management of Bowen's disease. Br J Dermatol 1999; 141: 633-41.
6. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-57.
7. Stables GI, Stringer MR, Robinson DJ, Ash DV. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 136: 957-60.
8. Morton CA, Whitehurst C, McColl JH et al. Photodynamic therapy for large or multiple patches of Bowen's disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-24.
9. Morton CA, Whitehurst C, Moseley H et al. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-71.
10. Cohen SS, Flaks JD, Barner HD et al. The mode of action of 5-fluorouracil and its derivatives. Proc Natl Acad Sci USA 1958; 44: 1004-12.
11. Goette DF. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol 1981; 4: 633-49.
12. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-72.
13. Sturm HM. Bowen's disease and 5-fluorouracil. J Am Acad Dermatol 1979; 1: 513-22.
14. Fulton JE, Carter DM, Hurley HJ. Treatment of Bowen's disease with topical 5-fluorouracil under occlusion. Arch Dermatol 1968; 97: 178-80.
15. Kurwa HA, Yong-Gee SA, Seed PT et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 1999; 41: 414-18.
16. Rud E, Gederaas O, Hogset A, Berg K. 5-Aminolaevulinic acid. but not 5-aminolaevulinic acid esters, is transported into adenocarcinoma cells by system beta transporters. Photochem Photobiol 2000; 71: 640-7.